Time X2 Test (p-value)
Per-post
X2 Test (p-value)
Pre-FU
Pre (n=103) Post (n=103) FU (n=103)
No. % No. % No. %
Hypertension:                
No 55 53.4 61 59.2 67 65.0    
Yes 48 46.6 42 40.8 36 35.0 0.71(0.40) 2.89(0.09)
Skin problem:                
No 1 1.0 8 7.8 62 60.2    
Yes 102 99.0 95 92.2 41 39.8 Fisher(0.04*) 85.08(<0.001*)
Edema:                
None 6 5.8 9 8.7 63 61.2    
Mild 11 10.7 87 84.5 26 25.2 126.65(<0.001*) 105.01(<0.001*)
Mod/severe 86 83.5 7 6.8 14 13.6    
Blood sugar:                
<126 18 17.5 20 19.4 31 30.1    
  126+ 85 82.5 83 80.6 72 69.9 0.13(0.72) 4.53(0.03*)
BMI:                
Normal 26 52.2 28 27.2 31 30.1    
Overweight 51 49.5 51 49.5 50 48.5 0.15(0.93) 0.78(0.68)
Obese 26 25.2 24 23.3 22 21.4    
Urea:                
Normal 31 30.1 36 35.0 41 39.8    
High 72 69.9 67 65.0 62 60.2 0.55(0.46) 2.14(0.14)
Creatinine:                
Normal 72 69.9 87 84.5 103 100.0    
High 31 30.1 16 15.5 0 0.0 6.20(0.1*) 36.49(<0.001*)
Uric acid:                
Normal 92 89.3 97 94.2 99 96.1    
High 11 10.7 6 5.8 4 3.9 1.60(0.21) 3.52(0.06)
(*) Statistically significant at p<0.05
Table 4: Physical and lab findings among patients in the study sample throughout study phases.